FDA Brief

Warning letters Drugs

FDA warning letter to

Infusion Options, Inc.

Issued Aug 26, 2021Posted Nov 9, 2021Division of Pharmaceutical Quality Operations I

Compounding Pharmacy/Adulterated Drug Products. We haven't summarized this letter yet. Read it on fda.gov.